Active, not recruitingPhase 3NCT02181257
Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts
Studying Transplant-related bronchiolitis obliterans
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Washington University School of Medicine
- Principal Investigator
- George J. Despotis, M.D.Washington University St. Louis School of Medicine
- Intervention
- Extracorporeal Photopheresis (ECP)(combination_product)
- Enrollment
- 280 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2015 – 2028
Study locations (22)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
- University of California San Diego, La Jolla, California, United States
- University of Florida, Gainesville, Florida, United States
- Northwestern University, Chicago, Illinois, United States
- Indiana University Health, Indianapolis, Indiana, United States
- University of Iowa, Iowa City, Iowa, United States
- University of Kentucky, Lexington, Kentucky, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- University of Michigan Health System, Ann Arbor, Michigan, United States
- Spectrum Health, Grand Rapids, Michigan, United States
- University of Minnesota Medical Center, Fairview, Minneapolis, Minnesota, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Columbia University, New York, New York, United States
- Duke University, Durham, North Carolina, United States
- +7 more locations on ClinicalTrials.gov
Collaborators
Centers for Medicare and Medicaid Services/ Coverage and Analysis Group · Therakos, Inc · The Foundation for Barnes-Jewish Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02181257 on ClinicalTrials.govOther trials for Transplant-related bronchiolitis obliterans
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07018804Mechanisms and Targeted Therapy of Airway Basal Cell Dysfunction in Bronchiolitis Obliterans SyndromeHaikou Affiliated Hospital of Central South University Xiangya School of Medicine
- RECRUITINGPHASE3NCT05654922Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung TransplantRenovion, Inc.
See all trials for Transplant-related bronchiolitis obliterans →